Skip to content

Crime & JusticeBreaking

FTC and seven states say Shkreli violated lifetime pharma industry ban

By

Coverage spectrum

Covered by 9 outlets across the spectrum.

9 articles in total. The spectrum counts each outlet once and leaves opinion out. How we measure bias

Man in glasses and grey blazer in front of pale stone columns, looking at camera.
Image via CNBCHow images are chosenReport this image

The Federal Trade Commission and seven states, including New York, have asked a federal judge to hold Martin Shkreli in contempt. They allege that he repeatedly violated a lifetime ban on taking part in the pharmaceutical industry. The filing, made on October 13 in the U.S. District Court for the Southern District of New York, alleges that he traded shares in at least 60 pharmaceutical companies and discussed their businesses through YouTube livestreams and posts on X and Reddit. The FTC said the action should serve as notice that it will not hesitate to enforce violations of court orders. A trial earlier found that Shkreli organized an illegal scheme to maintain a monopoly on the drug Daraprim, which led to the ban, according to CNBC.

Headline and summary written by Mantle’s AI from the coverage below, under published rules. How this works

What happened

Key points

Each point shows who reports it, from Far Left to Far Right.

  1. The FTC and seven states allege Martin Shkreli repeatedly violated his lifetime ban from the pharmaceutical industry.

    Across the spectrumReported byLeft3Center3Right1Far Right1See the outletsHide the outlets
    Left
    Business Insider, The Guardian, The New York Times
    Center
    CNBC, MarketWatch, The Hill
    Right
    The Washington Times
    Far Right
    The Epoch Times

  2. The FTC and seven states have asked a federal judge to hold Shkreli in contempt.

    Reported byLeft2Center2Far Right1See the outletsHide the outlets
    Left
    Business Insider, The Guardian
    Center
    CNBC, The Hill
    Far Right
    The Epoch Times

  3. The FTC filing alleges Shkreli traded shares in at least 60 pharmaceutical companies and influenced them through livestreams and social media posts.

    Reported byCenter1Right1Far Right1See the outletsHide the outlets
    Center
    MarketWatch
    Right
    The Washington Times
    Far Right
    The Epoch Times

  4. The filing was made on October 13 in the U.S. District Court for the Southern District of New York.

    Reported byCenter1Far Right1See the outletsHide the outlets
    Center
    The Hill
    Far Right
    The Epoch Times

  5. A trial found that Shkreli organized an illegal scheme to maintain a monopoly on the drug Daraprim, which led to the ban.

    Reported byCenter1Far Right1See the outletsHide the outlets
    Center
    CNBC
    Far Right
    The Epoch Times

  6. The FTC said it will not hesitate to enforce violations of court orders.

    One outletThe Epoch Times· Far Right

How each side tells it

Compare views

Every side reports that the FTC and seven states say Shkreli repeatedly broke his lifetime pharmaceutical ban and asked a federal judge to hold him in contempt. Left and center headlines attribute the claim to regulators, while the right stresses stock trading and the Pharma Bro nickname.

  • the left

    3 outlets

    Left headlines present the accusation as the regulators’ claim, using violated and seek contempt, while the New York Times calls Shkreli disgraced in its description.

    Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says
    The New York TimesLeftAll left-leaning headlines

  • the center

    3 outlets

    Center headlines attribute the accusation to the FTC and states, with The Hill and MarketWatch using the Pharma Bro nickname and MarketWatch stressing biopharma stocks.

    Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
    CNBCCenterAll center headlines

  • the right

    3 outlets

    Right headlines lead with the accusation and the Pharma Bro nickname, as the Washington Times does; the Far Right Epoch Times headline is plainer and names the FTC and states as accusers.

    'Pharma Bro' Martin Shkreli accused of violating court order by dealing in pharmaceuticals again
    The Washington TimesRightAll right-leaning headlines

The words they chose

Language to notice

Words that carry a judgement beyond the facts. Tap a highlighted word anywhere on the page to see why.

  • Left1

    disgraced

  • Center1

    notorious

  • Right2

    callous approach to price gougingis violating the terms

In the outlets’ own words

  • Loaded modifier

    notoriousMore neutral: former drug company executive

    The word judges Shkreli’s reputation in the outlet’s own voice rather than stating the court record.

    …Federal Trade Commission and seven states asked a federal judge on Tuesday to hold notorious "Pharma bro" Martin Shkreli in contempt, alleging he "flagrantly and repeatedly…

    Used byCNBC (Center)

  • Loaded modifier

    callous approach to price gougingMore neutral: known for his drug price increases

    “Callous” and “price gouging” are the writer’s judgements of Shkreli’s pricing, not findings in the filing it reports.

    Martin Shkreli, nicknamed the Pharma Bro for his callous approach to price gouging life-saving drugs, is violating the terms of his case by buying and…

    Used byThe Washington Times (Right)

  • Absolutist framing

    is violating the termsMore neutral: is accused of violating the terms

    The outlet states the alleged violation as fact in its own voice, while its headline says he is only accused.

    …the Pharma Bro for his callous approach to price gouging life-saving drugs, is violating the terms of his case by buying and selling pharmaceutical stocks, a coalition of…

    Used byThe Washington Times (Right)

  • Loaded modifier

    disgracedMore neutral: former or who resigned after

    Verdict as adjective; say what happened.

    …New York and six other states joined the Federal Trade Commission in accusing the disgraced former pharmaceutical executive of repeatedly violating the ban.

    Used byThe New York Times (Left)

Words quoted from someone else (1)Hide the quoted words

Loaded words that outlets reported someone else saying. They show what was said, not how the outlet chose to say it.

  • Sensational language

    Quoted

    flagrantly and repeatedlyMore neutral: repeatedly

    “Flagrantly” is the FTC’s own word for the alleged breaches, and the filing asserts it rather than a court having found it.

    …seven states asked a federal court on Tuesday to punish Martin Shkreli for "flagrantly and repeatedly” violating a lifetime ban from being involved in the pharmaceutical…

    Quoted byThe Hill (Center)

    These are Federal Trade Commission’s words. The outlets are reporting them.

See the full language guide

See for yourself

Side by side

What each side leads with and what it leaves out. Open a side to read its headlines.

From the left

3 outlets

Leads with

  • regulators accusation of repeated violations
  • flagrantly and repeatedly
  • seven states joining the FTC

Leaves out

  • the claim of trading in at least 60 pharmaceutical companies

Reported by other sides, not found in this side’s coverage.

See the 3 headlines from the leftHide the headlines
  • The New York TimesLeft

    Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says

    The attorneys general of New York and six other states joined the Federal Trade Commission in accusing the Loaded modifier“disgraced”Verdict as adjective; say what happened.More neutral: former, who resigned after, who was convicted ofDisagree with this highlight? former pharmaceutical executive of repeatedly violating the ban.

    Read at The New York Times (opens in a new tab)
  • The GuardianLeft

    FTC and seven states seek contempt ruling against Shkreli over pharma ban

    Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly …

    Read at The Guardian (opens in a new tab)
  • Business InsiderLeft

    FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban

    The Federal Trade Commission and seven state attorneys general want a federal judge to find Martin Shkreli in contempt.

    Read at Business Insider (opens in a new tab)

From the center

3 outlets

Leads with

  • contempt request
  • influence on biopharma stocks
  • lifetime industry ban

Leaves out

  • social media livestreams and posts as the channel

Reported by other sides, not found in this side’s coverage.

See the 3 headlines from the centerHide the headlines
  • The HillCenter

    FTC: 'Pharma bro' Shkreli violated lifetime industry ban, should be held in contempt

    The Federal Trade Commission (FTC) and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for "Sensational language“flagrantly and repeatedly”“Flagrantly” is the FTC’s own word for the alleged breaches, and the filing asserts it rather than a court having found it.More neutral: repeatedlyThese are Federal Trade Commission’s words. The outlet is reporting them.Disagree with this highlight?” violating a lifetime ban from being involved in the pharmaceutical industry. In a court filing in the U.S. …

    Read at The Hill (opens in a new tab)
  • MarketWatchCenter

    ‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks

    The controversial investor has been weighing in on biopharma stocks even though he’s banned from doing so.

    Read at MarketWatch (opens in a new tab)
  • CNBCCenter

    Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim

    Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.

    Read at CNBC (opens in a new tab)

From the right

3 outlets

Leads with

  • stock trading and social media posts
  • Pharma Bro nickname
  • violation of a court order
See the 3 headlines from the rightHide the headlines
  • New York PostRight

    ‘Pharma Bro’ Martin Shkreli broke lifetime ban on drug industry trades, fed say

    A federal judge is being asked to hold the ex-con in contempt and force him to surrender his trading profits and any pharmaceutical stocks he owns.

    Read at New York Post (opens in a new tab)
  • The Epoch TimesFar Right

    FTC, States Accuse Martin Shkreli of Violating Lifetime Pharma Ban

    Federal and state authorities have asked a judge to hold Martin Shkreli in civil contempt, accusing the former entrepreneur of influencing pharmaceutical stocks even though he is banned for life from being involved with the industry. …

    Read at The Epoch Times (opens in a new tab)
  • The Washington TimesRight

    'Pharma Bro' Martin Shkreli accused of violating court order by dealing in pharmaceuticals again

    Martin Shkreli, nicknamed the Pharma Bro for his Loaded modifier“callous approach to price gouging”“Callous” and “price gouging” are the writer’s judgements of Shkreli’s pricing, not findings in the filing it reports.More neutral: known for his drug price increasesDisagree with this highlight? life-saving drugs, Absolutist framing“is violating the terms”The outlet states the alleged violation as fact in its own voice, while its headline says he is only accused.More neutral: is accused of violating the termsDisagree with this highlight? of his case by buying and selling pharmaceutical stocks, a coalition of federal and state authorities said Tuesday.

    Read at The Washington Times (opens in a new tab)

Articles you open from here build My Mix, a private picture of how your reading spreads across the spectrum, kept on this device. What is My Mix?

The left is Far Left and Left together. The right is Right and Far Right together. Every outlet keeps its own five-point rating.

Who reported it when

How the coverage built up

  • Left

    1 hr 50 min later

    Its first report, Oct 13, 11:21 AM EDT

  • Center

    First to report

    CNBC, Oct 13, 9:32 AM EDT

  • Right

    4 hr 11 min later

    Its first report, Oct 13, 1:42 PM EDT

See the order the outlets reported inHide the order
  1. CNBCCenterOct 13, 9:32 AM EDT
  2. MarketWatchCenterOct 13, 11:17 AM EDT
  3. Business InsiderLeftOct 13, 11:21 AM EDT
  4. The GuardianLeftOct 13, 12:54 PM EDT
  5. The HillCenterOct 13, 1:05 PM EDT
  6. The Washington TimesRightOct 13, 1:42 PM EDT
  7. The New York TimesLeftOct 13, 2:48 PM EDT
  8. The Epoch TimesFar RightOct 13, 4:42 PM EDT
  9. New York PostRightOct 13, 6:24 PM EDT

Times are the ones the outlets published in their own feeds, in Eastern time. Opinion is left out.

Read next

Help someone else find the truth beneath the surface

Most people see one side of a story. Share this one, so they can see how every side is telling it and decide for themselves.

Email it

Seen a mistake? Tell us what is wrong with this page